Categories: Technology

Yuki Joins AWS ISV Accelerate (ISVA) Program to Bring Real-Time Data Cost Control to AI Workloads on Snowflake

TEL AVIV, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) — Yuki, the real-time orchestration platform for cloud data warehouses, today announced it has joined the Amazon Web Services (AWS) ISV Accelerate (ISVA) Program, a global co-sell program for AWS Partners who provide software solutions that run on or integrate with AWS and sell through AWS Marketplace.

As organizations deploy GenAI and LLM applications, they need to manage variable data workloads, with pipelines for embeddings, retrieval, evaluation, and agent-driven analytics layered on top of existing BI and ETL. Yuki enhances their ability to manage performance for these workloads while forecasting spend.

Yuki acts as the orchestration layer for Snowflake and BigQuery compute. It continuously interprets workload signals and automatically routes queries, right-sizes resources, and consolidates capacity in real time, reducing operational drag without trading off performance.

Last year, customers saved 42% on average, with onboarding in under an hour. As AI workloads increasingly span multiple data platforms, Yuki plans to expand support to additional environments, including Databricks, later this year.

The ISVA Program provides co-sell support and benefits that help AWS sellers engage with participating partners to drive joint customer outcomes, including collaboration with AWS field sellers globally.

“Most teams don’t have a tooling problem, they have a control problem,” said Perry Tapiero, Head of Marketing and GTM at Yuki. “AI-era data stacks make compute spiky and harder to govern, especially as pipelines multiply across teams. Yuki automatically routes workloads and right-sizes Snowflake and BigQuery in real time to improve performance and make spend predictable. ISVA helps us scale that value with AWS sellers and deliver faster outcomes for joint customers.”

Yuki is available in AWS Marketplace, enabling customers to procure through existing AWS agreements and streamline deployment. To learn more, visit Yuki in AWS Marketplace.

About Yuki

Yuki is a control platform for cloud data warehouses. Yuki automatically routes workloads and right-sizes compute across Snowflake and Google BigQuery to improve performance and make spend predictable. Yuki deploys privately in your environment with enterprise-grade governance and controls.

Media Contact
Orian Tal
The Pitch
orian@thepitch.media

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/f30df35f-8030-4346-a0bf-e85f523439d6

GlobeNews Wire

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

18 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

18 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

18 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

20 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

21 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

21 hours ago